PepGen Inc.
PEPGNasdaqCIK 1835597HealthcareFiscal year ends Dec 31
Reports and events: 96 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0607:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-336767 |
| 2026-08-0607:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336754 |
| 2026-06-2216:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-277579 |
| 2026-05-2107:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-233403 |
| 2026-05-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-219424 |
| 2026-05-1216:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219375 |
| 2026-04-2816:05 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001193125-26-186927 |
| 2026-03-3017:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-131786 |
| 2026-03-0417:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-091784 |
| 2026-03-0416:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-091536 |
| 2026-03-0416:11 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-091503 |
| 2025-12-0807:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310544 |
| 2025-11-1208:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-276019 |
| 2025-11-1208:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-276001 |
| 2025-11-0708:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-271089 |
| 2025-10-0116:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-226746 |
| 2025-09-3016:36 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-25-000009 |
| 2025-09-2607:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-218503 |
| 2025-09-2416:21 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-215435 |
| 2025-08-0708:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174982 |
| 2025-08-0708:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001193125-25-174979 |
| 2025-06-0608:29 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-082707 |
| 2025-05-2817:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-078428 |
| 2025-05-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066419 |
| 2025-05-0808:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066414 |
| 2025-04-2508:00 ET | DEF 14A | Proxy statementPeriod 2025-06-04 | 0000950170-25-058337 |
| 2025-03-3116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-047690 |
| 2025-03-2816:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-046746 |
| 2025-03-0408:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-031337 |
| 2025-02-2407:43 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-025232 |
| 2025-02-2407:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-025226 |
| 2025-01-2916:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-010515 |
| 2024-12-1608:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-136389 |
| 2024-11-0708:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122821 |
| 2024-11-0708:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122815 |
| 2024-10-0808:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-113410 |
| 2024-09-1916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-108126 |
| 2024-08-2008:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-098860 |
| 2024-08-0808:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093351 |
| 2024-08-0808:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093348 |
| 2024-07-3016:55 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-188977 |
| 2024-07-0208:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-080021 |
| 2024-06-2017:23 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-164587 |
| 2024-06-1108:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-071617 |
| 2024-05-1416:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059519 |
| 2024-05-1416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-059485 |
| 2024-04-2616:05 ET | DEF 14A | Proxy statementPeriod 2024-06-20 | 0000950170-24-049083 |
| 2024-03-2908:15 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-038417 |
| 2024-03-1516:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-069110 |
| 2024-03-1307:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-030505 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.